Monday, October 5, 2026
26.4 C
Bengaluru

Analysis of the Fastest Growing Companies and Therapy Areas in IPM – MAT Dec’24

  1. Growth Performance of Top 50 Companies in IPM (MAT Dec’24)

The top 50 pharmaceutical companies in the Indian Pharmaceutical Market (IPM) have grown significantly in various zones (West, South, North, and East). The following key insights emerge:
• The top 30 cities contributed 34% to IPM Sales for MAT Dec’24.
• The top cities grew at 8.5%, slightly higher than the overall IPM growth of 7.6%.
• Among mega metros, Delhi was the fastest-growing at 12.5%, followed by Chennai (11.6%) and Hyderabad (10.5%).
• Fastest-growing cities: Pune, Agra, Lucknow, Nashik, and Delhi saw the highest growth in demand.
• 13 out of the top 30 metros grew faster than the overall IPM, while 17 metros had growth equal to or lower than 7.6%.
• Reliance Life Sciences, Fresenius Kabi, and Merck Specialities were the fastest-growing in different regions, with growth rates exceeding 30-40%.

  1. Top 20 Fastest-Growing Companies by Zone

Each region showed distinct trends in terms of growth and key players:
• West Zone: AstraZeneca (28.6%), La Renon Healthcare (23.0%), Samarth Pharma (20.8%)
• South Zone: Reliance Life Sciences (47.6%), Fresenius Kabi (42.3%), Merck Specialities (30.9%)
• North Zone: AstraZeneca (37.7%), Bayer Pharma (33.9%), Aareen Healthcare (28.7%)
• East Zone: Hetero Healthcare (19.4%), Natco Pharma (18.9%), Corona Remedies (14.8%)

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical...

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

Topics

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...
spot_img

Related Articles

spot_imgspot_img